Privia Health Group Inc (PRVA)
Cash ratio
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | ||
---|---|---|---|---|
Cash and cash equivalents | US$ in thousands | 389,511 | 347,992 | 320,577 |
Short-term investments | US$ in thousands | — | — | — |
Total current liabilities | US$ in thousands | 386,952 | 264,274 | 190,461 |
Cash ratio | 1.01 | 1.32 | 1.68 |
December 31, 2023 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($389,511K
+ $—K)
÷ $386,952K
= 1.01
The cash ratio of Privia Health Group Inc has decreased over the past three years, from 1.73 in 2021 to 1.37 in 2022, and further to 1.06 in 2023. The declining trend indicates that the company's ability to cover its short-term liabilities solely with its available cash and cash equivalents has weakened over time. In 2023, for every dollar of current liabilities, the company only has $1.06 in cash and cash equivalents, compared to $1.37 in 2022 and $1.73 in 2021. This suggests that the company may be facing challenges in maintaining liquidity or managing its working capital efficiently. Further analysis of the company's cash management practices and overall financial health may be warranted to understand the reasons behind the declining cash ratio.
Peer comparison
Dec 31, 2023